* all times are in the U.S. Eastern Time Zone
| Feb 9, 2010 | 14:24 | Thermadyne Holdings Schedules 2010 Annual Shareholders Meeting |
 | Thermadyne Holdings Corporation (Nasdaq:THMD) announced today that its 2010 Annual Meeting of Shareholders will be held at 11:00 a.m., Eastern Time, Tuesday, April 27, 2009, at their Corporate Headquarters, 16052 Swingley Ridge Road, Suite 300, St. Louis, Mo. 63017. continued... |
|
| Feb 9, 2010 | 14:22 | Thermadyne Holdings Corporation to Present at the BB&T Capital Markets Manufacturing & Materials Conference on March 24, 2010 |
| Thermadyne Holdings Corporation (Nasdaq:THMD) will be presenting at the BB&T Capital Markets Manufacturing & Materials Conference on Wednesday, March 24, 2010 at The Waldorf Astoria Hotel in New York. continued... |
|
| Feb 9, 2010 | 14:19 | Thermadyne Holdings Announces Schedule and Webcast for 2009 Fourth-Quarter and Full-Year Financial Results |
| Thermadyne Holdings Corporation (Nasdaq:THMD) announced today it will release its fourth-quarter and full-year earnings after the close of the market on Tuesday, March 9, 2010. continued... |
|
| Feb 9, 2010 | 14:19 | Priority Capital Group Announces Pacific Office Properties Senior Common Stock |
 | Priority Capital Group and Pacific Office Properties Trust, Inc. (NYSE Amex:PCE) today announced commencement of the public offering of $400 million of Pacific Office senior common stock. The senior common stock, priced at $10 per share, offers a cumulative dividend of 7.25%, declared daily and paid monthly, plus the potential for dividend increases that are triggered by increases in the Pacific Office listed common stock dividend. continued... |
|
| Feb 9, 2010 | 14:18 | Thermadyne Holdings Corporation to Present at the JP Morgan Global High Yield & Leveraged Finance Conference on March 3, 2010 |
| Thermadyne Holdings Corporation (Nasdaq:THMD) will be presenting at the JP Morgan Global High Yield & Leveraged Finance Conference on Wednesday, March 3, 2010 at 8:45 am ET at The Loews Miami Beach Hotel in Miami, Florida. continued... |
|
| Feb 9, 2010 | 14:17 | Photo Release -- Northrop Grumman Names David Reith Vice President of Finance and Controller for Electronic Systems Sector |
 | Northrop Grumman Corporation (NYSE:NOC) has announced the appointment of David Reith as vice president of finance and controller for the company's Electronic Systems sector, effective immediately. continued... |
|
| Feb 9, 2010 | 13:57 | Photo Release -- Northrop Grumman Names Linnie Haynesworth Vice President and NPOESS Deputy Program Director |
 | Northrop Grumman Corporation (NYSE:NOC) has appointed Linnie Haynesworth vice president and deputy program director for the National Polar-orbiting Operational Environmental Satellite System (NPOESS). continued... |
|
| Feb 9, 2010 | 13:27 | Compuware Gomez Debuts Benchmark That Ranks "Big Game" TV Advertisers' Web Site Performance |
 | Compuware Gomez (Nasdaq:CPWR) today announced the inaugural Gomez Big Game Advertiser Web Benchmark, a first-of-its-kind ranking that takes into account the web site performance of brands that advertised during Sunday's Super BowlTM. continued... |
|
| Feb 9, 2010 | 12:38 | Tighe & Bond Joins VUEWorks Channel Partner Program |
| VUEWorks, Inc. is pleased to announce that Tighe & Bond, an award-winning firm specializing in civil and environmental engineering, has joined its channel partner program. Tighe & Bond will provide sales, implementation, and training for VUEWorks(r) GIS-integrated asset management solutions to municipal and utility clients throughout New England. continued... |
|
| Feb 9, 2010 | 12:24 | Automatic Data Processing Declares Regular Quarterly Dividend |
| The board of directors of Automatic Data Processing, Inc. (Nasdaq:ADP) has declared a regular quarterly dividend of 34 cents per share payable April 1, 2010 to shareholders of record on March 12, 2010. continued... |
|
| Feb 9, 2010 | 12:23 | Enrique Salem Elected ADP Director |
| The board of directors of Automatic Data Processing, Inc. (Nasdaq:ADP) has elected Enrique Salem, who is 44 years old, as a director of the company. continued... |
|
| Feb 9, 2010 | 12:19 | First Financial Northwest, Inc. Rings NASDAQ Opening Bell on February 18, 2010 |
| First Financial Northwest, Inc. (the "Company") (Nasdaq:FFNW), the holding company for First Savings Bank Northwest (the "Bank"), reported today that it will be participating in the NASDAQ Opening Bell Ceremony at the MarketSite in New York's Time Square, on Thursday, February 18, 2010. Victor Karpiak, Chairman, President and CEO of First Financial Northwest, Inc. will be joined by several Directors and members of management. continued... |
|
| Feb 9, 2010 | 12:08 | Shepherd Smith Edwards & Kantas LLP Investigates Claims for Clients of ING Financial Services, Signator Investors and Michael Joseph DiMare |
| The Securities Law Firm of Shepherd Smith Edwards & Kantas LLP, www.sseklaw.com, is currently investigating claims on behalf of Clients of ING Financial Services, a subsidiary of ING Group NV (NYSE:ING), Signator Investors and Michael Joseph DiMare. According to sources, DiMare may have solicited many of his clients to invest in a Ponzi scheme or some other rouse for extracting money from his clients. These solicitations may have occurred when he was employed by ING Financial Services and/or Signator. We believe Signator and ING could be held responsible for DiMare's actions as his respective former employers. If you were a client of ING Financial Services, Signator and/or Michael Joseph DiMare, we would like to hear from you. continued... |
|
| Feb 9, 2010 | 11:44 | Genesis Lease Limited Schedules Fourth Quarter and Year-End 2009 Earnings Conference Call for February 25, 2010 |
 | Genesis Lease Limited (NYSE:GLS) today announced that it plans to release its fourth quarter and year-end 2009 results on February 25, 2010 before the market opens. continued... |
|
| Feb 9, 2010 | 11:44 | Nymox Provides Update on Pivotal Phase 3 Trials for BPH Drug |
| Nymox Pharmaceutical Corporation (Nasdaq:NYMX) provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The first Safety Monitoring Committee meeting of 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated an acceptable ongoing safety evaluation of the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 60 well-known urology investigative sites throughout the U.S. The participating centers continue to evaluate and enroll patients and accrual is progressing well. The current Phase 3 trials incorporate specific protocol design recommendations made by the FDA at the earlier EOP2 meeting with the Company. For more information about the NX-1207 Phase 3 clinical trials, please go to www.clinicaltrials.gov or contact Nymox at info@nymox.com. continued... |
|
| More >>
* all times are in the U.S. Eastern Time Zone
